patent/NO-20090238-L

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20090238-L

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate	2009-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b53eeff0e783757ae51032f89e7fc85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae79cb5f11c49ece8b89e0717f15b9ed
publicationDate	2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	NO-20090238-L
titleOfInvention	Use of Thymosin-α1 for the Preparation of a Drug for the Treatment of Stage IV Malignant Melanoma
abstract	This describes the use of thymosin alfa in combination with dacarbazine and, if desired, Interferon alfa for the manufacture of a medicament for the treatment of stage IV malignant melanoma, which is characterized by remote, non-resectable metastases.
priorityDate	2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130571 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600775

Total number of triples: 26.